4-(((2-Hydroxy-7-methoxyquinolin-3-yl)methylene)amino)-3-thioxo-6-(3,4,5-trimethoxybenzyl)-3,4-dihydro-1,2,4-triazin-5(2H)-one

ID: ALA4869763

PubChem CID: 164622396

Max Phase: Preclinical

Molecular Formula: C24H23N5O6S

Molecular Weight: 509.54

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc2cc(/C=N/n3c(=S)[nH]nc(Cc4cc(OC)c(OC)c(OC)c4)c3=O)c(O)nc2c1

Standard InChI:  InChI=1S/C24H23N5O6S/c1-32-16-6-5-14-10-15(22(30)26-17(14)11-16)12-25-29-23(31)18(27-28-24(29)36)7-13-8-19(33-2)21(35-4)20(9-13)34-3/h5-6,8-12H,7H2,1-4H3,(H,26,30)(H,28,36)/b25-12+

Standard InChI Key:  YRXUTRCJAKQRSC-BRJLIKDPSA-N

Molfile:  

 
     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
   14.9557  -23.1991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9545  -24.0187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6626  -24.4276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6608  -22.7903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3694  -23.1955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3701  -24.0145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0787  -24.4216    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.7869  -24.0108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7822  -23.1886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0731  -22.7853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4874  -22.7757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1976  -23.1800    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.9028  -22.7671    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.6109  -23.1741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3140  -22.7647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3132  -21.9472    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.6032  -21.5407    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8939  -21.9518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1836  -21.5477    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   20.6132  -23.9913    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.0226  -23.1717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7294  -22.7614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4338  -23.1700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1401  -22.7605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1387  -21.9424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4251  -21.5356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7217  -21.9475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4962  -24.4166    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.4203  -20.7184    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.1256  -20.3057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8449  -21.5312    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.5541  -21.9373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8486  -23.1678    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.8501  -23.9850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2465  -24.4267    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.5391  -24.0175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 14 20  2  0
 15 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
  8 28  1  0
 26 29  1  0
 29 30  1  0
 25 31  1  0
 31 32  1  0
 24 33  1  0
 33 34  1  0
  2 35  1  0
 35 36  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4869763

    ---

Associated Targets(Human)

PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PTGS1 Cyclooxygenase-1 (5266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 509.54Molecular Weight (Monoisotopic): 509.1369AlogP: 3.06#Rotatable Bonds: 8
Polar Surface Area: 133.08Molecular Species: NEUTRALHBA: 11HBD: 2
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 7.36CX Basic pKa: 1.60CX LogP: 3.82CX LogD: 3.55
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.27Np Likeness Score: -0.86

References

1. Ghanim AM, Rezq S, Ibrahim TS, Romero DG, Kothayer H..  (2021)  Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition.,  219  [PMID:33892270] [10.1016/j.ejmech.2021.113457]

Source